Thanh bên bài viết

PDF
Ngày xuất bản: 25/11/2024
Số lượt xem tóm tắt: 24
Số lượt xem PDF: 11
DOI: https://doi.org/10.59873/vjid.v4i48.425
Số xuất bản
Tập 4 Số 48 (2024)
Chuyên mục
Nghiên cứu khoa học
Trích dẫn bài báo
Le, V. G. (2024). HEPATITIS VIRUS IS ONE OF THE MAIN CAUSATIVE AGENTS OF HEPATOCELLULAR CARCINOMA. Tạp chí Truyền nhiễm Việt Nam, 4(48). https://doi.org/10.59873/vjid.v4i48.425

HEPATITIS VIRUS IS ONE OF THE MAIN CAUSATIVE AGENTS OF HEPATOCELLULAR CARCINOMA

Le Van Giao1,
1 Central Hospital 71

Nội dung chính của bài viết

Tóm tắt

Despite the increasing incidence of HCC related to metabolism-associated steatotic liver disease, viral hepatitis remains the major driver in liver carcinogenesis. Both HCV and HBV viruses have direct oncogenic properties that promote carcinogenesis, especially in active infections. The aim of this review is to summarize the viral mechanisms involved in liver cancer and to evaluate the changing incidence of HCC after antiviral treatment.

Chi tiết bài viết

Từ khóa

Hepatitis B virus, hepatitis C virus, main agents, Hepatocellular carcinoma

Tài liệu tham khảo

1. Nguyen Phuong Thanh (2021). Research on the immunostimulating and anti-chronic hepatitis effects of livganic tablets in experiments, doctoral thesis in medicine, Hanoi Medical University.
2. Nguyen Thi Thu Huong (2020). Review of clinical and paraclinical characteristics of late-stage primary liver cancer, doctoral thesis in medicine, Hanoi Medical University.
3. Garuti, F.; Neri, A.; Avanzato, F.; Gramenzi, A.; Rampoldi, D.; Rucci, P.; Farinati, F.; Giannini, E.G.; Piscaglia, F.; et al. on behalf of the ITA.LI.CA
study group. The changing scenario of hepatocellular carcinoma in Italy: An update. Liver Int. 2021, 41, 585-597.
4. Fattovich, G.; Stroffolini, T.; Zagni, I.; Donato, F. Hepatocellular Carcinoma in Cirrhosis: Incidence and Risk Factors. Gastroenterology 2004, 127, S35-S50.
5. Calvaruso, V.; Cabibbo, G.; Cacciola, I.; Petta, S.; Madonia, S.; Bellia, A.; Tinè, F.; Distefano, M.; Licata, A.; Giannitrapani, L.; et al. on Behalf of
Rete Sicilia Selezione Terapia HCV (RESIST-HCV) Incidence of Hepatocellular Carcinoma in Patients With HCV Associated Cirrhosis Treated with DirectActing Antiviral Agents. Gastroenterology 2018,
155, 411-421.
6. Kanwal, F.; Kramer, J.; Asch, S.M.; Chayanupatkul, M.; Cao, Y.; El-Serag, H.B. Risk of Hepatocellular Cancer in HCV Patients Treated with
Direct-Acting Antiviral Agents. Gastroenterology 2017, 153, 996-1005.
7. El-Serag, H.B.; Kanwal, F.; Richardson, P.; Kramer, J. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology 2016, 64,
130-137.
8. Morisco, F.; Federico, A.; Marignani, M.; Cannavò, M.; Pontillo, G.; Guarino, M.; Dallio, M.; Pegini, P.; Benigno, R.G.; Lombardo, F.L.; et al.
Risk Factors for Liver Decompensation and HCC in HCV-Cirrhotic Patients after DAAs: A Multicenter Prospective Study. Cancers 2021, 13, 3810.
9. Kondili, L.A.; Quaranta, M.G.; Cavalletto, L.; Calvaruso, V.; Ferrigno, L.; D’Ambrosio, R.; Simonelli, I.; Brancaccio, G.; Raimondo, G.; Brunetto,
M.R.; et al. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort. Dig.
Liver Dis. 2023, 55, 907-917.
10. Chen, C.J.; Yang, H.I.; Su, J.; Jen, C.L.; You, S.L.; Lu, S.N.; Huang, G.T.; Iloeje, U.H.; REVEALHBV Study Group. Risk of hepatocellular carcinoma
across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006, 295, 65-73.
11. Raffetti, E.; Fattovich, G.; Donato, F. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: A systematic review and meta-analysis. Liver Int. 2016, 36, 1239-1251.
12. Papatheodoridis, G.V.; Sypsa, V.; Dalekos, G.N.; Yurdaydin, C.; Van Boemmel, F.; Buti, M.; Calleja, J.L.; Chi, H.; Goulis, J.; Manolakopoulos,
S.; et al. Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B. J. Hepatol. 2020, 72, 1088-1096.